The biotech industry is gearing up for a pivotal first quarter of 2024, with significant stock-moving events that investors and analysts will closely monitor. Notable happenings...
Barinthus Biotherapeutics has officially completed a reverse merger with a private biotechnology firm, a strategic move aimed at enhancing its market presence in the competitive biopharma...
